2021年2月17日 星期三

安全、效力高,資訊透明,才是疫苗廣為接受的條件:Sputnik V疫苗的故事

安全、效力高,資訊透明,才是疫苗廣為接受的條件:Sputnik V疫苗的故事


 On 2 February 2021, an interim analysis from the trial was published in The Lancet, indicating 91.6% efficacy without unusual side effects.[4]
https://en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine


According to preliminary review by experts, the lyophilized formulation of Gam-COVID-Vac is similar to the smallpox vaccine, circumventing the need for continuous cold chain storage – as required for the Pfizer–BioNTech and Moderna vaccines – and allowing transportation to remote locations with reduced risk of vaccine spoilage.

2.6 Sputnik V疫苗成搶手
匈牙利不管歐盟,自己用Sputnik V疫苗

■ Iran announced that its first batch of Covid-19 vaccine, Russia’s Sputnik Vwould arrive on Thursday.




WORLD

Putin’s once-scorned vaccine now favorite in pandemic fight


1.19

• 巴西批准科兴与阿斯利康疫苗,开启接种运动。此前一天,监管机构拒绝了俄罗斯研发的Sputnik V疫苗的紧急使用申请,称需要更多证明文件。官员表示,疫苗接种预计将于周三在巴西所有州开始。

沒有留言:

網誌存檔